| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.052 | 0.3 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.03 | 0.3 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.07 | 0.4 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.4 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |